» Articles » PMID: 11877490

Adjuvants of Immunity: Harnessing Innate Immunity to Promote Adaptive Immunity

Overview
Journal J Exp Med
Date 2002 Mar 6
PMID 11877490
Citations 37
Authors
Affiliations
Soon will be listed here.
Citing Articles

Optimizing the Efficacy of Vaccine-Induced Immunotherapy in Melanomas.

Chamseddine I, Kambara M, Bhatt P, Pilon-Thomas S, Rejniak K bioRxiv. 2025; .

PMID: 39829889 PMC: 11741369. DOI: 10.1101/2025.01.06.631283.


Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development.

Magazine N, Zhang T, Bungwon A, McGee M, Wu Y, Veggiani G Immunohorizons. 2024; 8(3):214-226.

PMID: 38427047 PMC: 10985062. DOI: 10.4049/immunohorizons.2400003.


Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development.

Magazine N, Zhang T, Bungwon A, McGee M, Wu Y, Veggiani G bioRxiv. 2023; .

PMID: 37961687 PMC: 10634854. DOI: 10.1101/2023.10.26.564184.


Immunoinformatics-aided design of a new multi-epitope vaccine adjuvanted with domain 4 of pneumolysin against Streptococcus pneumoniae strains.

Shafaghi M, Bahadori Z, Madanchi H, Ranjbar M, Shabani A, Mousavi S BMC Bioinformatics. 2023; 24(1):67.

PMID: 36829109 PMC: 9951839. DOI: 10.1186/s12859-023-05175-6.


Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitope.

Chang T, Manabe Y, Ito K, Yamamoto R, Kabayama K, Ohshima S RSC Adv. 2022; 12(29):18985-18993.

PMID: 35873332 PMC: 9241363. DOI: 10.1039/d2ra03286d.


References
1.
Hong S, Wilson M, Serizawa I, Wu L, Singh N, Naidenko O . The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med. 2001; 7(9):1052-6. DOI: 10.1038/nm0901-1052. View

2.
Singh A, Wilson M, Hong S, Olivares-Villagomez D, Du C, Stanic A . Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med. 2001; 194(12):1801-11. PMC: 2193577. DOI: 10.1084/jem.194.12.1801. View

3.
Kimbrell D, Beutler B . The evolution and genetics of innate immunity. Nat Rev Genet. 2001; 2(4):256-67. DOI: 10.1038/35066006. View

4.
Gallucci S, Lolkema M, Matzinger P . Natural adjuvants: endogenous activators of dendritic cells. Nat Med. 1999; 5(11):1249-55. DOI: 10.1038/15200. View

5.
Singh N, Hong S, Scherer D, Serizawa I, Burdin N, Kronenberg M . Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol. 1999; 163(5):2373-7. View